IN2002DE00891A - - Google Patents

Info

Publication number
IN2002DE00891A
IN2002DE00891A IN891DE2002A IN2002DE00891A IN 2002DE00891 A IN2002DE00891 A IN 2002DE00891A IN 891DE2002 A IN891DE2002 A IN 891DE2002A IN 2002DE00891 A IN2002DE00891 A IN 2002DE00891A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
John A Budny
Original Assignee
Pharmacal Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacal Biotechnologies Inc filed Critical Pharmacal Biotechnologies Inc
Publication of IN2002DE00891A publication Critical patent/IN2002DE00891A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN891DE2002 1997-10-16 2002-09-02 IN2002DE00891A (US06559137-20030506-C00112.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/951,393 US5871714A (en) 1997-10-16 1997-10-16 Compositions for controlling bacterial colonization

Publications (1)

Publication Number Publication Date
IN2002DE00891A true IN2002DE00891A (US06559137-20030506-C00112.png) 2005-01-21

Family

ID=25491643

Family Applications (1)

Application Number Title Priority Date Filing Date
IN891DE2002 IN2002DE00891A (US06559137-20030506-C00112.png) 1997-10-16 2002-09-02

Country Status (22)

Country Link
US (1) US5871714A (US06559137-20030506-C00112.png)
EP (1) EP1023084A1 (US06559137-20030506-C00112.png)
JP (1) JP2001519404A (US06559137-20030506-C00112.png)
KR (1) KR20010015757A (US06559137-20030506-C00112.png)
CN (1) CN1276732A (US06559137-20030506-C00112.png)
AU (1) AU742762B2 (US06559137-20030506-C00112.png)
BR (1) BR9812923A (US06559137-20030506-C00112.png)
CA (1) CA2306459A1 (US06559137-20030506-C00112.png)
CU (1) CU22838A3 (US06559137-20030506-C00112.png)
CZ (1) CZ20001237A3 (US06559137-20030506-C00112.png)
EA (1) EA002244B1 (US06559137-20030506-C00112.png)
HU (1) HUP0100016A2 (US06559137-20030506-C00112.png)
ID (1) ID24368A (US06559137-20030506-C00112.png)
IL (1) IL135628A0 (US06559137-20030506-C00112.png)
IN (1) IN2002DE00891A (US06559137-20030506-C00112.png)
MX (1) MXPA00003618A (US06559137-20030506-C00112.png)
NO (1) NO20001885L (US06559137-20030506-C00112.png)
NZ (1) NZ503974A (US06559137-20030506-C00112.png)
PL (1) PL339900A1 (US06559137-20030506-C00112.png)
TR (1) TR200000988T2 (US06559137-20030506-C00112.png)
WO (1) WO1999018999A1 (US06559137-20030506-C00112.png)
ZA (1) ZA989024B (US06559137-20030506-C00112.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159447A (en) * 1997-10-16 2000-12-12 Pharmacal Biotechnologies, Llc Compositions for controlling bacterial colonization
US6830745B1 (en) * 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US20020022005A1 (en) * 1997-10-16 2002-02-21 Budny John A. Compositions for treating cystic fibrosis
US5972311A (en) * 1998-01-26 1999-10-26 Duke University Method of preventing dental caries and other oral lesions
DE19909770A1 (de) 1999-03-05 2000-09-07 Werner Lubitz Bakterienghosts als Träger- und Targetingvehikel
US8522127B2 (en) 2001-07-16 2013-08-27 Robert G. Adamson, III Allowing operating system access to non-standard fonts in a network document
US10810355B1 (en) 2001-07-16 2020-10-20 Clantech, Inc. Allowing operating system access to non-standard fonts in a network document
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
AU2005332655A1 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
BRPI0719761A2 (pt) * 2006-12-01 2014-01-21 Laclede Inc Uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas orelhas
EP2178490B1 (en) * 2007-07-25 2019-09-04 3M Innovative Properties Company Film forming dental compositions
JP5628031B2 (ja) 2007-07-25 2014-11-19 スリーエム イノベイティブ プロパティズ カンパニー 治療用歯科用組成物及び関連する方法
EP2092834A1 (en) * 2008-02-19 2009-08-26 Innopact B.V. Methods and compositions of sphingolipid for preventing treating microbial infections
CN103261430A (zh) 2010-12-20 2013-08-21 纳幕尔杜邦公司 靶向过水解酶
EP2654695B8 (en) 2010-12-20 2020-03-04 DuPont US Holding, LLC Enzymatic peracid generation for use in oral care products
CN102219597B (zh) * 2011-04-11 2013-09-11 北京中农瑞利源高科技发展有限公司 酶控剂和酶控系列肥料及其在农业中的应用
US20120315260A1 (en) * 2011-06-13 2012-12-13 Svetlana A. Ivanova Compositions and Methods to Prevent and Treat Biofilms
US10420822B2 (en) 2011-06-13 2019-09-24 Ziolase, Llc Compositions and methods to prevent and treat biofilms
US9763881B2 (en) 2012-06-11 2017-09-19 Council Of Scientific And Industrial Research Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
KR102360720B1 (ko) * 2015-06-30 2022-02-10 (주)아모레퍼시픽 프라그 기질 용해제
CN111551416B (zh) * 2020-03-22 2021-08-06 华南理工大学 一种基于细胞膜磷脂酰丝氨酸荧光染色的细菌类凋亡评价方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1373487A (en) * 1970-10-26 1974-11-13 Guggenheim B Enzymes their preparation and uses
US4335101A (en) * 1971-08-10 1982-06-15 Merck & Co., Inc. Oral hygiene enzymes and method for preparation
JPS5536317B2 (US06559137-20030506-C00112.png) * 1972-04-22 1980-09-19
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
US4138476A (en) * 1977-08-03 1979-02-06 The United States Of America As Represented By The Secretary Of The Navy Plaque dispersing enzymes as oral therapeutic agents by molecular alteration
JPS57165312A (en) * 1981-04-03 1982-10-12 Handai Biseibutsubiyou Kenkyukai Production of oral composition
JPH0641424B2 (ja) * 1984-11-06 1994-06-01 ライオン株式会社 う蝕予防剤
US5306639A (en) * 1985-03-20 1994-04-26 Aizo Matsushiro DNA encoding glucanase enzymes
US4737359A (en) * 1985-04-18 1988-04-12 Colgate-Palmolive Company Control of dental plaque and caries using emulsan
GB8528761D0 (en) * 1985-11-22 1985-12-24 Axon Healthcare Ltd Enzyme-coupled antibodies
WO1991000112A1 (en) * 1989-06-30 1991-01-10 Brunswick Corporation Antibody-lactate oxidase conjugates
JPH0363215A (ja) * 1989-07-29 1991-03-19 Nakano Vinegar Co Ltd 歯垢分解組成物
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5320831A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5490978A (en) * 1993-10-15 1996-02-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Block copolymers of polysaccharides and polyalkylene oxides
EP0824019B1 (en) * 1996-08-13 2002-11-20 Quest International B.V. Inhibition or reduction of oral malodour

Also Published As

Publication number Publication date
AU742762B2 (en) 2002-01-10
CN1276732A (zh) 2000-12-13
US5871714A (en) 1999-02-16
AU9802898A (en) 1999-05-03
IL135628A0 (en) 2001-05-20
ID24368A (id) 2000-07-13
KR20010015757A (ko) 2001-02-26
CZ20001237A3 (cs) 2000-08-16
ZA989024B (en) 1999-04-07
NO20001885L (no) 2000-06-14
PL339900A1 (en) 2001-01-15
TR200000988T2 (tr) 2000-08-21
CA2306459A1 (en) 1999-04-22
MXPA00003618A (es) 2001-10-01
EP1023084A1 (en) 2000-08-02
NZ503974A (en) 2002-05-31
BR9812923A (pt) 2000-08-08
CU22838A3 (es) 2006-04-18
EA200000422A1 (ru) 2000-10-30
WO1999018999A1 (en) 1999-04-22
EA002244B1 (ru) 2002-02-28
JP2001519404A (ja) 2001-10-23
NO20001885D0 (no) 2000-04-12
HUP0100016A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
BE2018C032I2 (US06559137-20030506-C00112.png)
IN188419B (US06559137-20030506-C00112.png)
IN190037B (US06559137-20030506-C00112.png)
IN2002DE00891A (US06559137-20030506-C00112.png)
CH0944937H2 (US06559137-20030506-C00112.png)
IN187838B (US06559137-20030506-C00112.png)
ITMI971510A0 (US06559137-20030506-C00112.png)
IN191263B (US06559137-20030506-C00112.png)
ITGE970049A0 (US06559137-20030506-C00112.png)
BE2013C047I2 (US06559137-20030506-C00112.png)
BR9700653A (US06559137-20030506-C00112.png)
IN184040B (US06559137-20030506-C00112.png)
IN191446B (US06559137-20030506-C00112.png)
IN192094B (US06559137-20030506-C00112.png)
ITFI970061A0 (US06559137-20030506-C00112.png)
BR9701757A (US06559137-20030506-C00112.png)
ITMI971135A0 (US06559137-20030506-C00112.png)
ITUD970012V0 (US06559137-20030506-C00112.png)
CN3054162S (US06559137-20030506-C00112.png)
CN3055123S (US06559137-20030506-C00112.png)
CN3055713S (US06559137-20030506-C00112.png)
CN3056209S (US06559137-20030506-C00112.png)
CN3056251S (US06559137-20030506-C00112.png)
CN3056276S (US06559137-20030506-C00112.png)
CN3056417S (US06559137-20030506-C00112.png)